Clinical Biostatistics & Data Analysis

Alpha Spending Functions: O’Brien-Fleming, Pocock and Beyond Alpha Spending Functions: O’Brien-Fleming, Pocock and Beyond In the realm of clinical trials, the management of alpha spending during interim analyses is crucial for maintaining the integrity of statistical inferences. This guide aims to provide a comprehensive overview of alpha spending functions such as O’Brien-Fleming and Pocock, along…

Read More “Alpha Spending Functions: O’Brien-Fleming, Pocock and Beyond” »

When to Plan Interim Analyses for Efficacy, Futility and Safety When to Plan Interim Analyses for Efficacy, Futility and Safety Understanding Interim Analyses in Clinical Trials Interim analyses are critical evaluations conducted at predetermined time points during a clinical trial, primarily aimed at ensuring the study is on track in terms of efficacy, safety, and…

Read More “When to Plan Interim Analyses for Efficacy, Futility and Safety” »

Setting Up Independent Data Monitoring Committees (DMC/IDMC) The establishment and operation of Independent Data Monitoring Committees (DMC) or Independent Data Monitoring Committees (IDMC) is crucial in clinical trials for ensuring participant safety and the integrity of data. This guide provides a step-by-step approach to setting up a DMC, focusing on compliance with regulatory requirements in…

Read More “Setting Up Independent Data Monitoring Committees (DMC/IDMC)” »

Blinded vs Unblinded Interim Analyses: Operational and Regulatory Risks Blinded vs Unblinded Interim Analyses: Operational and Regulatory Risks In the realm of clinical trials, particularly adaptive platform trials, interim analyses serve as critical checkpoints that can influence the overall study trajectory. This tutorial aims to provide an in-depth understanding of the operational and regulatory risks…

Read More “Blinded vs Unblinded Interim Analyses: Operational and Regulatory Risks” »

Maintaining Trial Integrity and Confidentiality During Interim Looks Maintaining Trial Integrity and Confidentiality During Interim Looks Interim analyses play a critical role in the management and oversight of clinical trials. Ensuring the integrity and confidentiality of these analyses is imperative for the credibility of clinical research outcomes. With the increasing complexity of clinical trials, especially…

Read More “Maintaining Trial Integrity and Confidentiality During Interim Looks” »

Group-Sequential Designs: Statistical Concepts and Practical Execution Group-Sequential Designs: Statistical Concepts and Practical Execution In the landscape of clinical trials, the need for efficiency and ethical considerations is paramount. Group-sequential designs provide robust statistical methodologies that allow researchers to conduct interim analyses, ensuring that clinical trials can be adapted based on accumulating data. This article…

Read More “Group-Sequential Designs: Statistical Concepts and Practical Execution” »

Adaptive Enrichment and Sample Size Re-Estimation at Interim Adaptive Enrichment and Sample Size Re-Estimation at Interim The ever-evolving landscape of clinical trials necessitates a robust and flexible approach to data analysis. This is particularly true in the context of interim analyses, where decisions must be made based on incomplete data. This step-by-step guide focuses on…

Read More “Adaptive Enrichment and Sample Size Re-Estimation at Interim” »

Documenting Interim Analysis Plans in Protocol, SAP and Charter In the dynamically evolving landscape of clinical research, the necessity of interim analyses has become increasingly acknowledged by regulatory bodies and sponsors alike. Conducting interim analyses allows for the monitoring of data throughout the lifecycle of a clinical trial, potentially informing decisions regarding safety, efficacy, and…

Read More “Documenting Interim Analysis Plans in Protocol, SAP and Charter” »

Regulatory Expectations for Interim Analyses in Pivotal Programs Regulatory Expectations for Interim Analyses in Pivotal Programs Conducting clinical trials is a complex process governed by multiple regulatory frameworks, especially when it comes to pivotal programs. Among the many components of clinical trial design, interim analyses stand out as critical milestones. This article aims to provide…

Read More “Regulatory Expectations for Interim Analyses in Pivotal Programs” »

Case Studies: Interim Analyses That Stopped Trials Early—for Good or Bad Case Studies: Interim Analyses That Stopped Trials Early—for Good or Bad Interim analyses play a crucial role in the management and evaluation of clinical trials. By analyzing data at predetermined intervals, researchers can make informed decisions about the continuation or termination of a trial….

Read More “Case Studies: Interim Analyses That Stopped Trials Early—for Good or Bad” »